Femasys (FEMY) P/E (2021 - 2026)
Femasys (FEMY) P/E from Jun 18, 2021 to Jul 21, 2026. The TTM Femasys (FEMY) P/E is -0.69. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Femasys (FEMY)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.69 | -38.14% |
| 2025 | -1.12 | -14.74% |
| 2024 | -1.32 | +26.03% |
| 2023 | -1.04 | +6.59% |
| 2022 | -0.98 | -85.56% |
| 2021 | -6.78 | N/A |
Comparison Femasys (FEMY) P/E with competitors
Femasys (FEMY) P/E is -0.69.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -132.26% |
| EMBC | Embecta Corp | 1.69 | -343.53% |
| SOLV | Solventum Corp | 9.49 | -1467.61% |
| ZJYL | Jin Medical International Ltd | 12.75 | -1936.57% |
| PDEX | Pro-Dex Inc (co) | 15.22 | -2292.81% |
| RMD | Resmed Inc | 19.04 | -2844.02% |
| UTMD | Utah Medical Products Inc | 20.76 | -3091.08% |
| ATR | Aptargroup Inc | 21.65 | -3218.95% |
| ALGN | Align Technology Inc | 30.29 | -4464.45% |
| HOLX | Hologic Inc | 30.86 | -4546.93% |
| MMSI | Merit Medical Systems Inc | 31.15 | -4587.57% |
| STVN | Stevanato Group Spa | 31.25 | -4603.13% |
| LMAT | Lemaitre Vascular Inc | 36.34 | -5335.98% |
| ALC | Alcon Inc | 41.51 | -6081.51% |
| ISRG | Intuitive Surgical Inc | 46.43 | -6789.30% |
| BDX | Becton Dickinson & Company | 46.93 | -6862.00% |
| WST | West Pharmaceutical Services Inc | 47.41 | -6930.54% |
| NEPH | Nephros Inc | 50.00 | -7303.54% |
| COO | Cooper Companies Inc | 58.98 | -8597.69% |
| NNNN | Anbio Biotechnology - Class A | 62.20 | -9061.75% |
| NVST | Envista Holdings Corp | 64.66 | -9416.85% |
| BAX | Baxter International Inc | 72.66 | -10568.41% |
| ICUI | ICU Medical Inc | 84.82 | -12321.03% |
| RGEN | Repligen Corp | 162.20 | -23469.52% |
| WRBY | Warby Parker Inc - Class A | 318.30 | -45960.90% |